Antihypertensive Treatment and Secondary Prevention of Cardiovascular Disease Events Among Persons Without Hypertension A Meta-analysis

Antihypertensive Treatment and Secondary Prevention of Cardiovascular Disease Events Among Persons Without Hypertension A Meta-analysis

Por: Angela M. Thompson, MSPH, Tian Hu, MS, BM. Carrie L. Eshelbrenner, MD, Kristi Reynolds, PhD, Jiang He, MD, PhD y Lydia A. Bazzano, MD, PhD. JAMA, March 2, 2011—Vol 305, No. 9.

Among adults 35 years and older, more than 17% of those with normal blood pressure and 37% of those with blood pressure in the prehypertensive range (130-139mmHg systolic, 86-89 mmHg diastolic) progress to overt hypertension within 4 years without changes in lifestyle or pharmacological intervention.6 In adults 55 years and older, lifetime risk of developing hypertension is greater than 90%.

_____________________________________________________________________

Pharmacotherapy for mild hypertension.
Cochrane Database Syst Rev. 2012 Aug 15;8:CD006742. (Review)